Sign In
to Vote &
Create Storyboards.
 

Medical News

Location American Medical News for 6 July 2019
(University of Texas M. D. Anderson Cancer Center) The 3-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer ...
Read More
4
0
(European Society for Medical Oncology) some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study reported at the ESMO World Congress on Gastrointestinal Cancer 2019 ...
Read More
1
0
(European Society for Medical Oncology) New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer.
Read More
1
0

{TITLE}

{PUBLISHER} - {PUBLISHED_DATE}
{TITLE} {CONTENT}
Read More
{VIEWS}
0


Storyboard
Print
{VIEWS}
0
0




Share this Article

Location



Create Storyboard